Intrinsic Value of S&P & Nasdaq Contact Us

HeartBeam, Inc. BEAT NASDAQ

NASDAQ Capital Marke • Healthcare • Medical - Healthcare Information Services • US • USD

SharesGrow Score
49/100
3/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$5.00
+316.7%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

HeartBeam, Inc. (BEAT) has a negative trailing P/E of -1.9, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. The forward P/E of 4.0 based on analyst estimates suggests a return to profitability is expected. Trailing earnings yield is -52.83%, forward earnings yield 25.00%. PEG 0.03 (Peter Lynch undervalued ≤1.0).

Criteria proven by this page:

  • VALUE (100/100, Pass) — PEG ≤ 1.0 — Peter Lynch undervalued (0.03); analyst target implies upside (+316.7%).
  • Forward P/E 4.0 — analysts expect a return to profitability with estimated EPS of $0.30 for FY2029.
  • PEG Ratio 0.03 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
  • Trailing Earnings Yield -52.83% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings. Forward yield improves to 25.00% as earnings recover.
  • Analyst consensus target $5.00 (+316.7% upside) — significant upside potential according to Wall Street analysts.

Overall SharesGrow Score: 47/100 with 3/7 criteria passed.

SharesGrow 7-Criteria Score
49/100
SG Score
View full scorecard →
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
FUTURE
73/100
Analyst consensus
→ Forecast
PAST
0/100
→ Income
HEALTH
75/100
Debt-to-Equity & liquidity
→ Health
MOAT
28/100
→ Income
GROWTH
15/100
→ Income
INCOME
N/A
No coverage

Valuation Snapshot — BEAT

Valuation Multiples
P/E (TTM)-1.9
Forward P/E4.0
PEG Ratio0.03
Forward PEG0.03
P/B Ratio15.28
P/S Ratio0.00
EV/EBITDA-1.7
Per Share Data
EPS (TTM)$-0.62
Forward EPS (Est.)$0.30
Book Value / Share$0.08
Revenue / Share$0.00
FCF / Share$-0.43
Yields & Fair Value
Earnings Yield-52.83%
Forward Earnings Yield25.00%
Dividend Yield0.00%
Analyst Target$5.00 (+316.7%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2016 2.5 0.00 0.94 0.63 -
2017 -8.9 0.07 0.57 0.50 -
2018 3.9 -0.01 0.54 0.42 -
2019 -71.5 0.66 -10.28 0.00 -
2020 -35.9 -0.76 -8.01 0.00 -
2021 -5.4 -0.02 1.79 0.00 -
2022 -3.1 -0.02 16.79 0.00 -
2023 -3.3 0.06 3.00 0.00 -
2024 -3.2 -2.27 37.05 0.00 -
2025 -3.8 0.26 31.08 0.00 -

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2016 $1.75 $208.33M $53.44M 25.6%
2017 $-0.53 $286.78M $-15.96M -5.6%
2018 $1.20 $399.47M $42.82M 10.7%
2019 $-0.10 $0.00 $-778K -
2020 $-0.17 $0.00 $-1.07M -
2021 $-1.03 $0.00 $-4.43M -
2022 $-1.59 $0.00 $-12.96M -
2023 $-0.72 $0.00 $-14.64M -
2024 $-0.73 $0.00 $-19.45M -
2025 $-0.62 $0.00 $-21.02M -

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $-0.52 $-0.61 – $-0.43 $2.08M $624.78K – $3.96M 4
2027 $-0.43 $-0.44 – $-0.42 $8.04M $5.48M – $9.81M 3
2028 $-0.20 $-0.25 – $-0.11 $25.21M $24.09M – $26.33M 3
2029 $0.30 $0.15 – $0.48 $64.49M $40.03M – $94.48M 1
2030 $0.71 $0.36 – $1.13 $114.32M $70.96M – $167.49M 1
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message